http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MY-103746-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cf32b60391b469c41e86c353437f5751
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2123-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S930-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S930-16
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-6555
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-31
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-12
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-27
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-655
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-31
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-575
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
filingDate 1988-07-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_017b5a1a0664689a599f280ace653117
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8bcf45a12d82ed0f5a9e8ffc78a1def8
publicationDate 1993-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber MY-103746-A
titleOfInvention Improvements in or relating to somatostatins
abstract THE INVENTION PROVIDES A PHARMACEUTICAL COMPOSITION COMPRISING A SOMATOSTATIN ANALOGUE, AND ITS USE IN THE TREATMENT OF BREAST CANCER. THE PHARMACEUTICAL COMPOSITION PREFERABLY CONTAINS LACTIC ACID IN DDITION TO THE SOMATOSTATIN ANALOGUE AND IS BETTER TOLERATED WHEN ADMINISTERED BY INJECTION.
priorityDate 1987-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID612
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419560844
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16129706
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID417109324

Total number of triples: 37.